BioFire Diagnostics Gets $25M Investment | GenomeWeb

NEW YORK (GenomeWeb News) – BioFire Diagnostics today announced that it has received a $25 million investment from Athyrium Opportunities Fund.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.